Published by
@ShahidNShah
@ShahidNShah
7th Annual RNA-Targeted Drug Discovery & Development Summit is sheduled on December 10-12, 2024 in Boston, USA.With Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering with Depixus, there has been many valuable collaborations entering the RNA-targeting field accelerating efficacious and selective small molecules targeting RNA directly, RNA-binding proteins and RNA/protein complexes.Hence, as the go-to meeting for the RNA-targeting small molecule the community, the 7th Annual RNA-Targeted Drug Discovery and Development Summit returns to Boston this December. Increase your knowledge of RNA tertiary structures, delve into innovative preclinical modelling strategies and identify optimal chemical features for advancing specific, efficacious and safe small molecules.
[Read on rna-drugdiscovery.com](https://rna-drugdiscovery.com/take-part/register/)
Continue reading at rna-drugdiscovery.com
December 10 to December 12, 2024
Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 13, 2024 at 11:52am